MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 98 filers reported holding MAXCYTE INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,134,529 | -44.5% | 1,325,170 | -18.3% | 0.00% | -100.0% |
| Q2 2023 | $7,445,058 | -10.5% | 1,622,017 | -3.5% | 0.00% | 0.0% |
| Q1 2023 | $8,320,302 | -2.3% | 1,680,869 | +7.7% | 0.00% | 0.0% |
| Q4 2022 | $8,520,445 | -12.0% | 1,560,521 | +4.8% | 0.00% | 0.0% |
| Q3 2022 | $9,680,000 | +31.6% | 1,489,241 | -4.2% | 0.00% | 0.0% |
| Q2 2022 | $7,354,000 | -19.2% | 1,554,840 | +19.4% | 0.00% | 0.0% |
| Q1 2022 | $9,101,000 | -35.1% | 1,301,977 | -5.4% | 0.00% | -50.0% |
| Q4 2021 | $14,024,000 | -11.3% | 1,376,225 | +6.3% | 0.00% | 0.0% |
| Q3 2021 | $15,802,000 | – | 1,294,199 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NORTH RUN CAPITAL, LP | 480,900 | $3,361,000 | 4.94% |
| Casdin Capital, LLC | 13,971,334 | $97,660,000 | 4.38% |
| Vitruvian Partners LLP | 4,385,670 | $30,656,000 | 3.25% |
| RIVER GLOBAL INVESTORS LLP | 2,100,000 | $14,849,000 | 1.95% |
| APIS CAPITAL ADVISORS, LLC | 180,000 | $1,258,000 | 1.52% |
| Pier Capital, LLC | 1,017,753 | $7,114,000 | 0.91% |
| First Light Asset Management, LLC | 1,321,406 | $9,237,000 | 0.82% |
| Montanaro Asset Management Ltd | 929,000 | $6,557,000 | 0.81% |
| Nicholas Investment Partners, LP | 776,963 | $5,431,000 | 0.39% |
| Bleichroeder LP | 250,000 | $1,764,000 | 0.31% |